Connect with us

Hi, what are you looking for?

Smart Success StrategySmart Success Strategy

Investing

HHS halts work at high-risk infectious disease lab following repeated safety violations

The Department of Health and Human Services (HHS) implemented a pause on research at one of the nation’s most highly secure research labs, following repeated safety incidents that a source familiar told Fox News Digital have been occurring since the Biden administration.

An HHS official confirmed the pause at Fort Detrick’s Integrated Research Facility, which conducts risky research on deadly infectious diseases like SARS-COV-2 and the Ebola virus, began Tuesday at 5 p.m. 

The facility, which is one of only a handful across North America, is part of the National Institute of Allergy and Infectious Diseases (NIAID) and is located at the U.S. Army base Fort Detrick, outside Washington, D.C. The research there studies treatment and prevention of deadly, ‘high-consequence’ diseases such as Lassa Fever and Eastern equine encephalitis.

According to the HHS official who was willing to speak on the matter under the condition of anonymity, the pause stemmed from a lover’s spat between researchers at the facility, which resulted in one of the individuals poking holes in the other’s personal protective equipment (PPE). That individual has since been fired, the official indicated. 

The HHS official added that the incident is just the latest example of safety incidents at the high-risk laboratory, which they blamed on a poor safety culture at the lab enabled by the previous Biden administration.

‘NIH and HHS take the safety of our facilities and research very seriously,’ HHS spokesperson Andrew Nixon said. ‘As soon as we found out about this incident, we took immediate action to issue the safety pause until we can correct the safety culture at this facility.’

The latest incident, according to HHS, was preceded by a separate incident that occurred as recently as November.

The facility’s director, Connie Schmaljohn, was placed on administrative leave following the incident. The HHS official familiar with the matter indicated Schmaljohn did not report the incident up the chain of command immediately, causing a delay in remedying the matter.

During this temporary pause, all research at the facility will come to a halt and access will be limited to essential personnel. 

It is unclear how long the pause will remain in effect.   

This post appeared first on FOX NEWS
Enter Your Information Below To Receive Latest News, And Articles.



    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    The energy revolution is here to stay, and electric vehicles (EVs) have become part of the mainstream narrative. Despite geopolitical tensions and uncertainty, the...

    Editor's Pick

    Overview Mexico’s Sinaloa state hosts a number of prolific silver and gold mines, including McEwen Mining’s (TSX:MUX) El Gallo Complex, Americas Gold and Silver’s...

    Editor's Pick

    Uranium is an important energy sector commodity, and its rising value has attracted investor interest. 2023 has seen uranium prices solidly above the important...

    Investing

    A new survey shows that the presidential race between former President Donald Trump and President Biden is thin, but Biden faces a deficit in...

    Disclaimer: smartsuccessstrategy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartsuccessstrategy.com